INS and metabolic dysfunction-associated steatotic liver disease: Elevation in plasma insulin concentrations and disruptions in insulin signaling are often the repercussions of obesity and insulin resistance and constitute hallmarks of these conditions which are risk factors of NAFLD [18,19].